Article

Addressing Comorbid Migraine in Obese Patients

Morbidly or severely obese individuals develop migraine disorders significantly more often than patients who carry less weight.

Morbidly or severely obese individuals develop migraine disorders significantly more often than patients who carry less weight.

Obese patients are at higher risk for both episodic and chronic migraines, and that risk increases as they gain more weight. Researchers have suggested that pathophysiological abnormalities, such as changes in hypothalamic activation and modulation of shared neurotransmitters and proteins, and/or lifestyle choices may be the cause.

Limited, uncontrolled research has shown bariatric surgery reduces headache frequency and pain intensity. In an article published in Future Neurology, 2 authors discussed researchers’ efforts to date and areas of treatment that appear promising. In fact, several studies have demonstrated partial resolution of migraine symptoms as patients lost weight.

The study authors pointed out that none of the studies included a control group, so they reminded readers that larger controlled studies evaluating bariatric surgery for migraine prevention are still needed. Many obese patients who have migraines are poor candidates for bariatric surgery or do not desire the procedure. In this population, studies assessing other weight-loss strategies like diet and exercise are also needed, the authors said.

The article advocated for clinicians to proactively advise patients on the increased risk of migraine among those who are obese. It also recommended choosing medications carefully when patients are obese, as many medications’ side effects include weight gain or loss.

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
© 2024 MJH Life Sciences

All rights reserved.